polymyositis
polymyositis
Explore linked clinical trials. Standard reference: MONDO:001912763 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) | Skin and Connective Tissue Diseases, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Phase 2 | 2026-10-09 | NCT07111065 | |
| Environmental Risk Factors for the Anti-synthetase Syndrome | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, dermatomyositis, immune system disorder, juvenile polymyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Not stated | 2026-10-08 | NCT01276470 | |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | CNS demyelinating autoimmune disease, Crohn disease, Digestive System Diseases, Hemic and Lymphatic Diseases, Neoplasms by Site, Sjogren syndrome, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, bone disorder, colitis, colonic disorder, connective tissue disorder, demyelinating disease, dermatomyositis, digestive system disorder, dry eye syndrome, eye disorder, gastroenteritis, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, immune system disorder, inflammatory bowel disease, intestinal disorder, lacrimal apparatus disorder, mouth disorder, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, neoplasm, nervous system disorder, neuromuscular disease, polymyositis, psoriasis, psoriatic arthritis, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, spondylitis, systemic lupus erythematosus, systemic sclerosis, ulcerative colitis, vertebral column disorder | Recruiting | Phase 1 | 2026-10-05 | NCT03816345 | |
| A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) | Skin and Connective Tissue Diseases, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Phase 3 | 2026-09-24 | NCT06455449 | |
| Natural History of Inflammatory Muscle Diseases | Skin and Connective Tissue Diseases, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Not stated | 2026-09-24 | NCT05738824 | |
| Adult and Juvenile Myositis | Skin and Connective Tissue Diseases, connective tissue disorder, dermatomyositis, inclusion body myositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Not stated | 2026-09-24 | NCT00017914 | |
| A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy | Skin and Connective Tissue Diseases, antisynthetase syndrome, connective tissue disorder, dermatomyositis, immune-mediated necrotizing myopathy, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Enrolling by invitation | Phase 3 | 2026-09-21 | NCT05979441 | |
| RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy | Dermatomyositis, Childhood Type, Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, dermatomyositis, immune system disorder, immune-mediated necrotizing myopathy, juvenile polymyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-17 | NCT06154252 | |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis. | Skin and Connective Tissue Diseases, acquired idiopathic inflammatory myopathy, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dermatomyositis, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic lupus erythematosus | Recruiting | Phase 1 | 2026-09-15 | NCT06916806 | |
| A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] | Skin and Connective Tissue Diseases, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Phase 3 | 2026-09-15 | NCT05895786 | |
| Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study | Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2026-09-15 | NCT03582800 | |
| A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, dermatomyositis, diffuse scleroderma, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nephritis, nervous system disorder, neuromuscular disease, polymyositis, skin disorder, systemic lupus erythematosus, systemic sclerosis, urinary system disorder | Recruiting | Phase 1 | 2026-09-10 | NCT07085104 | |
| FT839 in Autoimmune Diseases | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, dermatomyositis, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, polymyositis, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis | Recruiting | Phase 1 / Phase 2 | 2026-09-02 | NCT07800871 | |
| Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study | Skin and Connective Tissue Diseases, amyopathic dermatomyositis, connective tissue disorder, dermatomyositis, interstitial lung disease, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, respiratory system disorder, skin disorder | Recruiting | Phase 2 | 2026-08-25 | NCT07486869 | |
| A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies | Skin and Connective Tissue Diseases, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Phase 3 | 2026-08-25 | NCT06698796 | |
| Pain-Sleep in Rheumatic Disease | Dyssomnias, Neurologic Manifestations, Pain, Parasomnias, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, Sleep Disorders, Intrinsic, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, dermatomyositis, immune system disorder, insomnia, juvenile idiopathic arthritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, psychiatric disorder, rheumatic disorder, skin disorder, sleep-wake disorder, systemic lupus erythematosus, vascular disorder, vasculitis | Not yet recruiting | Not applicable | 2026-08-20 | NCT07775612 | |
| BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dermatomyositis, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nephritis, nervous system disorder, neuromuscular disease, polymyositis, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic lupus erythematosus, systemic sclerosis, urinary system disorder | Not yet recruiting | Phase 1 | 2026-07-28 | NCT07729995 | |
| Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, connective tissue disorder, dermatomyositis, immune system disorder, juvenile myasthenia gravis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, polymyositis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 1 / Phase 2 | 2026-07-27 | NCT07089121 | |
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | Behcet disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, anterior uveitis, antiphospholipid syndrome, autoimmune disease, blood coagulation disease, blood platelet disease, bullous pemphigoid, cardiovascular disorder, connective tissue disorder, dermatomyositis, eye disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, panuveitis, polymyositis, purpura, skin disorder, skin vascular disease, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy, uveal disorder, uveitis, vascular disorder, vasculitis, vesiculobullous skin disease | Recruiting | Phase 1 | 2026-07-22 | NCT06371417 | |
| BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy | Skin and Connective Tissue Diseases, antisynthetase syndrome, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder | Recruiting | Phase 1 | 2026-07-20 | NCT07715136 | |
| Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) | Behcet disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, anterior uveitis, antiphospholipid syndrome, autoimmune disease, blood coagulation disease, blood platelet disease, bullous pemphigoid, cardiovascular disorder, connective tissue disorder, dermatomyositis, eye disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, panuveitis, polymyositis, purpura, skin disorder, skin vascular disease, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy, uveal disorder, uveitis, vascular disorder, vasculitis, vesiculobullous skin disease | Enrolling by invitation | Phase 1 | 2026-07-17 | NCT06723106 | |
| A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, Skin and Connective Tissue Diseases, Urogenital Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dermatomyositis, diffuse scleroderma, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nephritis, nervous system disorder, neuromuscular disease, polymyositis, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic lupus erythematosus, systemic sclerosis, urinary system disorder | Recruiting | Phase 1 | 2026-07-14 | NCT07115745 | |
| Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty | Axial Spondyloarthritis, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, anti-neutrophil cytoplasmic antibody-associated vasculitis, arteritis, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, connective tissue disorder, dermatomyositis, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, juvenile idiopathic arthritis, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, polymyalgia rheumatica, polymyositis, psoriasis, psoriatic arthritis, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, spondylitis, systemic lupus erythematosus, temporal arteritis, vascular disorder, vasculitis, vertebral column disorder | Recruiting | Phase 2 | 2026-07-09 | NCT07138898 | |
| Phase 2 Study of Rapcabtagene Autoleucel in Myositis | Skin and Connective Tissue Diseases, acquired idiopathic inflammatory myopathy, connective tissue disorder, dermatomyositis, interstitial lung disease, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, respiratory system disorder, skin disorder | Active, not recruiting | Phase 2 | 2026-06-23 | NCT06665256 | |
| Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases | Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Infections, Lichenoid Eruptions, Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Suppuration, atopic eczema, bacterial infectious disease, connective tissue disorder, cutaneous vasculitis, dermatitis, dermatomyositis, hereditary disease, hereditary skin disorder, hidradenitis, hidradenitis suppurativa, immune system disorder, lichen planus, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, psoriasis, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, skin vascular disease, sweat gland disorder | Recruiting | Not stated | 2026-06-12 | NCT06599411 |